Back
MannKind Corp. 10K Form
Sell
14
MNKD
MannKind Corp.
Last Price:
$2.49
Seasonality Move:
6.53%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | MNKD/MannKind Corp. Quarterly |
| 2023-11-07 | 10Q | MNKD/MannKind Corp. Quarterly |
| 2023-08-07 | 10Q | MNKD/MannKind Corp. Quarterly |
| 2023-05-09 | 10Q | MNKD/MannKind Corp. Quarterly |
| 2022-11-08 | 10Q | MNKD/MannKind Corp. Quarterly |
| 2022-08-09 | 10Q | MNKD/MannKind Corp. Quarterly |
Receive MNKD News And Ratings
See the #1 stock for the next 7 days that we like better than MNKD
MNKD Financial Statistics
Sales & Book Value
| Annual Sales: | $349M |
|---|---|
| Cash Flow: | $-9.4M |
| Price / Cash Flow: | 55.89 |
| Annual Sales: | $-0.17 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 0.01680 |
|---|---|
| Net Income (TTM): | $5.9M |
| Gross Margin: | $257M |
| Return on Equity: | 0% |
| Return on Assets: | 1.17% |
MannKind Corp. Earnings Forecast
Key MannKind Corp. Financial Ratios
-
The Gross Profit Margin over the past 26 years for MNKD is 73.66%.
-
The Selling, General & Administrative Expenses for MNKD have been equal to 41.30% of Gross Profit Margin.
-
The Research & Development expenses have been 19.01% of Revenue.
-
The Interest Expense is 648.63% of Operating Income.
-
The Net Earning history of MNKD is 1.68% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 16 years.
MannKind Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MNKD |
| CUSIP: | 56400P |
| Website: | mannkindcorp.com |
Debt
| Debt-to-Equity Ratio: | -9.28 |
|---|---|
| Current Ratio: | 1.7 |
| Quick Ratio: | 1.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 130.79 |
|---|---|
| Forward P/E Ratio: | 10.75 |
MNKD Technical Analysis vs Fundamental Analysis
Sell
14
MannKind Corp. (MNKD)
is a Sell
Is MannKind Corp. a Buy or a Sell?
-
MannKind Corp. stock is rated a SellThe current MannKind Corp. [MNKD] share price is $2.50. The Score for MNKD is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.